{
    "organizations": [],
    "uuid": "6b4a9915f3a7aa9116261030a5eedcbae55edb28",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-santhera-pharmaceuticals-reports-o/brief-santhera-pharmaceuticals-reports-outcome-of-exploratory-trial-with-idebenone-in-ppms-conducted-at-nih-idUSFWN1QN02T",
    "ord_in_thread": 0,
    "title": "BRIEF-Santhera Pharmaceuticals ‍Reports Outcome Of Exploratory Trial With Idebenone In PPMS Conducted At NIH​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING Ag :\n* ‍REPORTS OUTCOME OF EXPLORATORY TRIAL WITH IDEBENONE IN PPMS CONDUCTED AT NIH​\n* SANTHERA - ‍EXPLORATORY PHASE I/II CLINICAL TRIAL CONFIRMS SAFETY PROFILE OF IDEBENONE AT A DOSE OF 2,250 MG DAILY OVER A TREATMENT PERIOD OF TWO YEARS​\n* SANTHERA - ‍IN ASSESSING EFFICACY ON DISEASE PROGRESSION, NO DIFFERENCE BETWEEN ACTIVE TREATMENT GROUP AND PLACEBO WAS OBSERVED​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-05T14:30:00.000+02:00",
    "crawled": "2018-03-06T22:28:56.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "santhera",
        "pharmaceutical",
        "holding",
        "ag",
        "outcome",
        "exploratory",
        "trial",
        "idebenone",
        "ppms",
        "conducted",
        "santhera",
        "phase",
        "clinical",
        "trial",
        "confirms",
        "safety",
        "profile",
        "idebenone",
        "dose",
        "mg",
        "daily",
        "treatment",
        "period",
        "two",
        "santhera",
        "assessing",
        "efficacy",
        "disease",
        "progression",
        "difference",
        "active",
        "treatment",
        "group",
        "placebo",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}